Abstract
Early identification of patients who may develop into clinical deterioration is necessary to prevent complications and death from COVID-19. This research aims to determine the association between lymphocyte-to-monocyte ratio (LMR) and survival in Coronavirus disease-2019 (COVID-19) patients. This study used a retrospective cohort design. We collected survival data retrospectively by tracing medical records to gather data on demographic, clinical, and laboratory characteristics. Mann-Whitney U test was used to determine the difference in LMR values in the survivor and non-survivor groups. A total of 502 subjects were involved in this study. The LMR value was significantly lower in the non-survivors group compared to the survivors group (p=0.001). We found an adjusted odds ratio (OR) of LMR of 3.62; 95% confidence interval (CI) 1.92-14.25; p=0.046). LMR can reflect the disease severity and can be used to predict prognosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
